Table 2 Odds ratios for the association of weight and prescribed medication for obstructive airway disease in patients with mild to moderate chronic obstructive pulmonary disease

From: Overweight in patients with chronic obstructive pulmonary disease needs more attention: a cross-sectional study in general practice

  

Normal weight N = 1534

Overweight N = 2212

Obesity N = 1192

≥1 prescription SAMA

No. cases

128

175

106

 

Model 1

ref.

0.94 (0.74–1.20)

1.07 (0.82–1.40)

 

Model 2

ref.

0.96 (0.74–1.24)

1.13 (0.84–1.51)

≥1 prescription SABA

No. cases

321

530

339

 

Model 1

ref.

1.19 (1.02–1.39)

1.50 (1.26–1.79)

 

Model 2

ref.

1.26 (1.06–1.50)

1.55 (1.28–1.89)

≥1 prescription LAMA

No. cases

647

999

574

 

Model 1

ref.

1.13 (0.99–1.29)

1.27 (1.09–1.48)

 

Model 2

ref.

1.13 (0.97–1.31)

1.24 (1.05–1.47)

≥1 prescription LABA

No. cases

183

289

164

 

Model 1

ref.

1.11 (0.91–1.35)

1.18 (0.94–1.48)

 

Model 2

ref.

0.98 (0.79–1.22)

0.99 (0.77–1.28)

≥1 prescription ICS

No. cases

192

302

136

 

Model 1

ref.

1.11 (0.91–1.34)

0.90 (0.71–1.14)

 

Model 2

ref.

1.03 (0.83–1.27)

0.78 (0.61–1.01)

≥1 prescription combination LABA+ICS

No. cases

664

943

583

 

Model 1

ref.

0.97 (0.85–1.11)

1.25 (1.08–1.46)

 

Model 2

ref.

1.01 (0.88–1.18)

1.31 (1.11–1.56)

≥1 prescription prednisone

No. cases

307

442

266

 

Model 1

ref.

1.00 (0.85–1.17)

1.15 (0.95–1.38)

 

Model 2

ref.

1.05 (0.88–1.25)

1.20 (0.98–1.47)

≥1 prescription antibiotics

No. cases

411

557

323

 

Model 1

ref.

0.92 (0.79–1.07)

1.02 (0.86–1.20)

 

Model 2

ref.

0.93 (0.79–1.09)

1.02 (0.85–1.23)

  1. Odds ratios are presented with their 95% confidence interval
  2. Model 1: crude model (N = 4938)
  3. Model 2: adjusted for clustering effect of general practice, gender, age, smoking status, and lung function (N = 4583)
  4. SAMA short-acting muscarinic antagonist, SABA short acting beta2-antagonist, LAMA long-acting muscarinic antagonist, LABA long-acting beta2-antagonist, ICS inhaled corticosteroids